google-site-verification=sVM5bW4dz4pBUBx08fDi3frlhMoRYb75bthh-zE8SYY Targeted MenB Jabs for Year 11 Students in Kent - TAX Assistant

Targeted MenB Jabs for Year 11 Students in Kent

By Tax assistant

Published on:

Targeted MenB Jabs for Year 11 Students in Kent

The UK Health Security Agency (UKHSA) has officially expanded its emergency vaccination programme to include Year 11 pupils at several schools in Kent. This targeted move aims to contain the most significant Meningitis B (MenB) outbreak seen in the UK in a generation.

Thank you for reading this post, don't forget to subscribe!

While the outbreak appears to be stabilizing, with total confirmed and probable cases adjusted to 23 (down from a peak of 34 due to laboratory reclassifications), health officials are not taking any chances.

Who is eligible?

The vaccination offer is no longer limited just to university students. The new criteria include:

  • Year 11, 12, and 13 students at four specific secondary schools in the Kent area with confirmed or suspected cases.
  • University of Kent & Canterbury Christ Church University students and staff.
  • Club Chemistry Attendees: Anyone who visited or worked at the Canterbury nightclub between March 5 and March 15.
  • Close Contacts: Anyone who was previously offered preventative antibiotics as part of this outbreak.

Note: If you are eligible but have already traveled away from Kent for the Easter break, you can receive the vaccine and antibiotics at your local GP practice.

Why the expansion?

The decision to include Year 11s (typically 15-16 year olds) is a “precautionary measure” driven by several factors:

  1. High Transmission Risk: Teenagers and young adults are the most likely to carry the meningococcal bacteria asymptomatically in their throats, facilitating rapid spread in social settings.
  2. Vaccination Gap: The MenB vaccine was only added to the routine NHS schedule for babies in 2015. This means most current secondary and university students are unprotected unless they were vaccinated privately.
  3. Strain Sensitivity: Genetic analysis has confirmed that the Bexsero vaccine being used is highly effective against this specific “explosive” strain of the disease.

Symptoms: “Don’t Wait for the Rash”

Health Secretary Wes Streeting has urged everyone in the region to remain vigilant. The MenB strain can cause a rapid decline in health. Seek medical help immediately if you or a child experience:

  • Sudden high fever and vomiting.
  • A severe, worsening headache or stiff neck.
  • Dislike of bright lights or cold hands and feet.
  • A rash that does not fade under a glass (though this often appears late).

Current Outbreak Stats (as of March 24)

  • Confirmed/Probable Cases: 23
  • Fatalities: 2 (one university student, one school student)
  • Antibiotic Doses Issued: Over 13,000
  • Vaccinations Administered: Over 10,000